ZYME Relative Valuation
ZYME's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ZYME is overvalued; if below, it's undervalued.
Historical Valuation
Zymeworks Inc (ZYME) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -3.72. The fair price of Zymeworks Inc (ZYME) is between NaN to NaN according to relative valuation methord.
Relative Value
Fair Zone
NaN-NaN
Current Price：26.59
Fair
-27.40
PE
1Y
3Y
5Y
Trailing
Forward
212.81
EV/EBITDA
Zymeworks Inc. (ZYME) has a current EV/EBITDA of 212.81. The 5-year average EV/EBITDA is 2.39. The thresholds are as follows: Strongly Undervalued below -57.04, Undervalued between -57.04 and -27.33, Fairly Valued between 32.11 and -27.33, Overvalued between 32.11 and 61.82, and Strongly Overvalued above 61.82. The current Forward EV/EBITDA of 212.81 falls within the Strongly Overvalued range.
-16.50
EV/EBIT
Zymeworks Inc. (ZYME) has a current EV/EBIT of -16.50. The 5-year average EV/EBIT is -3.32. The thresholds are as follows: Strongly Undervalued below -10.21, Undervalued between -10.21 and -6.77, Fairly Valued between 0.12 and -6.77, Overvalued between 0.12 and 3.57, and Strongly Overvalued above 3.57. The current Forward EV/EBIT of -16.50 falls within the Strongly Undervalued range.
20.95
PS
Zymeworks Inc. (ZYME) has a current PS of 20.95. The 5-year average PS is 19.20. The thresholds are as follows: Strongly Undervalued below -38.26, Undervalued between -38.26 and -9.53, Fairly Valued between 47.93 and -9.53, Overvalued between 47.93 and 76.66, and Strongly Overvalued above 76.66. The current Forward PS of 20.95 falls within the Historic Trend Line -Fairly Valued range.
-44.34
P/OCF
Zymeworks Inc. (ZYME) has a current P/OCF of -44.34. The 5-year average P/OCF is -15.02. The thresholds are as follows: Strongly Undervalued below -504.78, Undervalued between -504.78 and -259.90, Fairly Valued between 229.87 and -259.90, Overvalued between 229.87 and 474.75, and Strongly Overvalued above 474.75. The current Forward P/OCF of -44.34 falls within the Historic Trend Line -Fairly Valued range.
22.17
P/FCF
Zymeworks Inc. (ZYME) has a current P/FCF of 22.17. The 5-year average P/FCF is -4.16. The thresholds are as follows: Strongly Undervalued below -37.01, Undervalued between -37.01 and -20.58, Fairly Valued between 12.27 and -20.58, Overvalued between 12.27 and 28.70, and Strongly Overvalued above 28.70. The current Forward P/FCF of 22.17 falls within the Overvalued range.
Zymeworks Inc (ZYME) has a current Price-to-Book (P/B) ratio of 6.16. Compared to its 3-year average P/B ratio of 2.06 , the current P/B ratio is approximately 198.31% higher. Relative to its 5-year average P/B ratio of 2.47, the current P/B ratio is about 149.56% higher. Zymeworks Inc (ZYME) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 2.23%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -12.25% , the current FCF yield is about -100.00% lower.
6.23
P/B
Median3y
2.06
Median5y
2.47
-3.34
FCF Yield
Median3y
2.23
Median5y
-12.25
Competitors Valuation Multiple
The average P/S ratio for ZYME's competitors is 0.00, providing a benchmark for relative valuation. Zymeworks Inc Corp (ZYME) exhibits a P/S ratio of , which is NaN% above the industry average. Given its robust revenue growth of 72.59%, this premium appears sustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
Performance Decomposition
1Y
3Y
5Y
Market capitalization of ZYME increased by 81.15% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 16.00M to 27.61M.
The secondary factor is the P/E Change, contributed 70.51%to the performance.
Overall, the performance of ZYME in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
FAQ
Is Zymeworks Inc (ZYME) currently overvalued or undervalued?
What is Zymeworks Inc (ZYME) fair value?
How does ZYME's valuation metrics compare to the industry average?
What is the current P/B ratio for Zymeworks Inc (ZYME) as of Dec 05 2025?
What is the current FCF Yield for Zymeworks Inc (ZYME) as of Dec 05 2025?
What is the current Forward P/E ratio for Zymeworks Inc (ZYME) as of Dec 05 2025?